Latest news

• 20 May 2022

  Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer

  Lugano, Switzerland, May 19, 2022 – Helsinn Group, a fully...
• 17 May 2022

  Helsinn to present data at upcoming AMMF’s 2022 European Cholangiocarcinoma Conference

  Lugano, Switzerland, May 11, 2022 - Helsinn Group...
• 17 May 2022

  Knight Therapeutics and Helsinn Healthcare SA Enter into Exclusive License, Distribution, and Supply Agreement for Akynzeo® and Aloxi®

  MONTREAL, Quebec and LUGANO, Switzerland – May 12, 2022 –...